Cabergoline for hyperprolactinemia.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D001971:Bromocriptine; D000077465:Cabergoline; D003365:Costs and Cost Analysis; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004873:Ergolines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D011388:Prolactin / Q000097:blood*
D018491:Dopamine Agonists; D004873:Ergolines; D001971:Bromocriptine; D011388:Prolactin; D000077465:Cabergoline